Interpace Diagnostics Thyroid Tests Covered In-Network by BCBS of Michigan

Jul 31, 2019

|

NEW YORK – Parsippany, New Jersey-based Interpace Diagnostics announced today that it has signed a contract with Blue Cross Blue Shield of Michigan to cover its ThyGeNext and ThyraMir thyroid cancer detection assays as an in-network service, limiting the insurer's members' out-of-pocket expenses.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Menu

Interpace Diagnostics Thyroid Tests Covered In-Network by BCBS of Michigan

To read the full story....

Breaking News

Abbott POC Coronavirus Test Snares FDA Emergency Use Authorization

Luminex Receives FDA Emergency Use Authorization for Coronavirus Multiplex Panel

Gradientech Awarded $634K for Commercialization of AST Platform

UK Government Invests $28M in FIND to Support SARS-CoV-2 Test Development

Biolidics to Acquire Singapore Lab and Testing Business for up to S$3.7M

Sysmex Obtains Japan Marketing Approval to Distribute BGI Genomics Coronavirus Kit

Featured White Papers

What's Popular?

Oncocyte Details Plans for Rapidly Expanded Test Menu

Germline Genetic Testing, Counseling Move Remote as Pandemic Limits In-Person Care Capacity

Japanese Regulators Approve Merck KGaA MET Inhibitor With ArcherDx CDx

Biocept More Than Doubles Q4 Revenues; Full-Year Revenues Grow 70 Percent

Biolidics to Acquire Singapore Lab and Testing Business for up to S$3.7M

Sponsorships